Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better

Published:2021-08-31 Issue:9 Volume:38 Page:1593-1600
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Li Huimin,Di Jiaxing,Peng Baowei,Xu Yuhong^ORCID,Zhang Ning

Funder

National Natural Science Foundation of China

Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-021-03092-y.pdf

Reference35 articles.

1. Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–34.

2. Park J, Park JE, Hedrick VE, Wood KV, Bonham C, Lee W, et al. A comparative in vivo study of albumin-coated paclitaxel nanocrystals and Abraxane. Small. 2018;14(16):1703670.

3. Hood ED, Greineder CF, Shuvaeva T, Walsh L, Villa CH, Muzykantov VR. Vascular targeting of radiolabeled liposomes with bio-orthogonally conjugated ligands: single chain fragments provide higher specificity than antibodies. Bioconjug Chem. 2018;29(11):3626–37.

4. Niwa T, Kasuya Y, Suzuki Y, Ichikawa K, Yoshida H, Kurimoto A, et al. Novel Immunoliposome Technology for Enhancing the activity of the agonistic antibody against the tumor necrosis factor receptor superfamily. Mol Pharm. 2018;15(9):3729–40.

5. Sheng Y, Hu J, Shi J, Lee LJ. Stimuli-responsive carriers for controlled intracellular drug release. Curr Med Chem. 2017;26(13):2377–88.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Strategies for Site-Specific mRNA Delivery;Bioconjugate Chemistry;2024-03-16

2. Nanoparticle Delivery in Microvascular after Cerebral Ischemia: A Simulation Study;Applied Bionics and Biomechanics;2024-02-07

3. The role of formulation approaches in presenting targeting ligands on lipid nanoparticles;Nanomedicine;2023-03

4. Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy;mAbs;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3